Stock Price
135.37
Daily Change
2.13%
Yearly
-27.13%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Takeda 3,324.00 19.00 0.57% -7.44%
Astellas Pharma 1,906.00 12.50 0.66% 10.98%
Eisai 6,042.00 61.00 1.02% -21.80%
Daiichi Sankyo 2,594.50 27.50 1.07% -28.11%
AbbVie 134.70 -0.51 -0.38% 21.07%
Acadia Pharmaceuticals 22.15 0.28 1.28% -57.41%
Agios Pharmaceuticals 31.14 0.11 0.35% -34.79%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 231.73 0.43 0.19% -8.05%
Bayer 52.64 0.52 1.00% -0.38%
Biogen 229.14 -1.67 -0.72% -15.17%
Bluebird Bio 7.17 -0.38 -5.03% -84.69%
BioMarin Pharmaceutical 86.50 0.50 0.58% -0.44%
Bristol-Myers Squibb 65.25 0.53 0.81% 1.66%
Celldex Therapeutics 30.96 0.64 2.11% 72.67%
Clovis Oncology 2.46 0.02 0.61% -61.52%
Esperion Therapeutics 3.89 0.16 4.29% -84.72%
Exelixis 17.34 0.26 1.52% -18.67%
Genmab 2,270.00 -23.00 -1.00% -14.02%
Gilead Sciences 68.47 -0.61 -0.88% 2.22%
GlaxoSmithKline 1,633.60 -32.80 -1.97% 19.70%
Glaxosmithkline 45.13 -0.56 -1.22% 19.47%
Immunogen 5.75 -0.10 -1.63% -24.90%
Incyte Corp 75.74 0.96 1.28% -19.34%
Insmed 22.96 0.74 3.33% -45.44%
Karyopharm Therapeutics 8.15 0.69 9.25% -45.88%
Eli Lilly 247.24 2.19 0.89% 22.18%
MacroGenics 13.38 0.13 0.94% -40.10%
Merck & Co 81.34 0.05 0.06% 0.20%
Moderna Inc 172.38 -1.69 -0.97% 29.63%
Mirati Therapeutics 123.50 2.69 2.23% -42.00%
Nektar Therapeutics 12.40 0.26 2.14% -25.57%
Novartis 81.35 -0.11 -0.14% -4.98%
Puma Biotechnology 2.69 0.09 3.27% -74.67%
Pfizer 54.04 0.50 0.94% 48.15%
Regeneron Pharmaceuticals 618.20 0.09 0.01% 15.45%
Sanofi 92.95 1.22 1.33% 14.16%
Seattle Genetics 135.37 2.82 2.13% -27.13%
Spectrum Pharmaceuticals 1.06 -0.01 -0.93% -73.10%
Sarepta Therapeutics 66.02 2.87 4.54% -31.88%
Teva Pharmaceutical Industries Ltd 2,744.00 -83.00 -2.94% -32.75%
Vertex Pharmaceuticals 232.32 1.48 0.64% -2.65%
Xencor 35.88 0.91 2.60% -25.42%

Indexes Price Day Year
NASDAQ 14496 155.31 1.08% 7.13%

Seattle Genetics
Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in the development and sale of pharmaceutical products on its own, behalf or in collaboration with others. The Company is commercializing ADCETRIS, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas; PADCEV or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, and TUKYSA, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. The Company also develops a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs. Its programs, including ADCETRIS and PADCEV, are based on its antibody-drug conjugate (ADC), technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The Company's approved medicines include ADCETRIS, PADCEV and TUKYSA.